PV logo

PV Stock

Profile

Full Name:

Primavera Capital Acquisition Corporation

Sector:

Financial Services

Industry:

Shell Companies

Country:

Hong Kong

IPO:

15 March 2021

Indexes:

Not included

Website:

http://pvspac.com

Description:

Primavera Capital Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more operating businesses. The company was incorporated in 2020 and is based in Central, Hong Kong.

Key Details

Price

-

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

$0.41

PE Ratio

-

Annual ROE

5.54%

Annual Debt To Equity

0.00

Beta

-

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

May 12, 2023

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with PV included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price All-time High

$10.52
PV price is currently at an all-time high

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Operating Profit

-$3.46 M
PV annual operaing income is -$3.46 million

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual ROE

5.54%
PV annual return on equity is 5.54%

Annual ROA

5.03%
PV annual return on assets is 5.03%

Annual EBIT

-$3.46 M
PV annual earnings before interest & taxes is -$3.46 million

Annual EBITDA

-$3.46 M
PV annual earnings before interest, taxes, depreciation & amortization is -$3.46 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Current Ratio

0.20
PV annual current ratio is 0.20

Annual Total Assets

$415.12 M
PV annual total assets is $415.12 million

Annual Current Assets

$523.60 K
PV annual total current assets is $523.60 thousand

Annual Total Liabilities

$38.01 M
PV annual total liabilities is $38.01 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual FCF

-$1.17 M
PV annual free cash flow is -$1.17 million

Institutional Ownership

Similar stocks

ees Europe: Battery Storage – Powerbanks for the Energy Transition
ees Europe: Battery Storage – Powerbanks for the Energy Transition
ees Europe: Battery Storage – Powerbanks for the Energy Transition
PV
businesswire.com04 June 2024

MUNICH & PFORZHEIM, Germany--(BUSINESS WIRE)--Battery storage is booming. According to a study by Frontier Economics, the volume of grid-connected storage in Germany alone could increase to 60 gigawatts (GW) or 271 gigawatt-hours (GWh) by 2050. This is forty times the current storage capacity. Similar dynamics in cost reduction and installation speed are expected as seen with photovoltaics (PV) in recent years. Soon, battery storage will fundamentally change energy supply. The latest technologi.

BESREMi® (Ropeginterferon alfa-2B) Shows Greatest Benefit Among Cytoreductive Therapies in Lowering Symptomatic Burden of Polycythemia Vera (PV): Real-World Analysis Published at ASCO
BESREMi® (Ropeginterferon alfa-2B) Shows Greatest Benefit Among Cytoreductive Therapies in Lowering Symptomatic Burden of Polycythemia Vera (PV): Real-World Analysis Published at ASCO
BESREMi® (Ropeginterferon alfa-2B) Shows Greatest Benefit Among Cytoreductive Therapies in Lowering Symptomatic Burden of Polycythemia Vera (PV): Real-World Analysis Published at ASCO
PV
businesswire.com29 May 2024

BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, announced today results from a real-world data review published in the Journal of Clinical Oncology supplement (abstract # e18530) for the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting Proce.

FAQ

  • What is the primary business of Primavera Capital Acquisition?
  • What is the ticker symbol for Primavera Capital Acquisition?
  • Does Primavera Capital Acquisition pay dividends?
  • What sector is Primavera Capital Acquisition in?
  • What industry is Primavera Capital Acquisition in?
  • What country is Primavera Capital Acquisition based in?
  • When did Primavera Capital Acquisition go public?
  • Is Primavera Capital Acquisition in the S&P 500?
  • Is Primavera Capital Acquisition in the NASDAQ 100?
  • Is Primavera Capital Acquisition in the Dow Jones?
  • When was Primavera Capital Acquisition's last earnings report?
  • When does Primavera Capital Acquisition report earnings?

What is the primary business of Primavera Capital Acquisition?

Primavera Capital Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more operating businesses. The company was incorporated in 2020 and is based in Central, Hong Kong.

What is the ticker symbol for Primavera Capital Acquisition?

The ticker symbol for Primavera Capital Acquisition is NYSE:PV

Does Primavera Capital Acquisition pay dividends?

No, Primavera Capital Acquisition does not pay dividends

What sector is Primavera Capital Acquisition in?

Primavera Capital Acquisition is in the Financial Services sector

What industry is Primavera Capital Acquisition in?

Primavera Capital Acquisition is in the Shell Companies industry

What country is Primavera Capital Acquisition based in?

Primavera Capital Acquisition is headquartered in Hong Kong

When did Primavera Capital Acquisition go public?

Primavera Capital Acquisition's initial public offering (IPO) was on 15 March 2021

Is Primavera Capital Acquisition in the S&P 500?

No, Primavera Capital Acquisition is not included in the S&P 500 index

Is Primavera Capital Acquisition in the NASDAQ 100?

No, Primavera Capital Acquisition is not included in the NASDAQ 100 index

Is Primavera Capital Acquisition in the Dow Jones?

No, Primavera Capital Acquisition is not included in the Dow Jones index

When was Primavera Capital Acquisition's last earnings report?

Primavera Capital Acquisition's most recent earnings report was on 12 May 2023

When does Primavera Capital Acquisition report earnings?

The date for Primavera Capital Acquisition's next earnings report has not been announced yet